Anses, Back to home Anses, Back to home Anses, Back to home Anses, Back to home

Quick access

Dernier article liste article

Enterohaemorrhagic E. coli (EHEC) infection and how you can prevent it

Updated on 23/06/2022

Escherichia coli (E. coli) is a bacterium found naturally in the digestive microflora of humans and warm-blooded animals. While most Escherichia coli strains are safe for humans, certain strains such as enterohaemorrhagic E. coli (EHEC) cause potentially severe infections, primarily in young children and the elderly.

read more

The article has been added to your library

Go to your library
COVID-19: all ANSES's news

Updated on 10/05/2022

Since the beginning of the pandemic, ANSES has been making its expertise available to public decision-makers for the prevention of COVID-19-related health risks. The Agency has also been offering its expertise in its specific areas of competence – food and nutrition, animal health, occupational health, etc. – to provide the public with useful guidelines on how to organise daily life and protect health during this period. This page lists all the work carried out by the Agency and provides an overview of its organisation at this unprecedented time.

Export certification

Updated on 21/06/2022

ANSES-ANMV can issue certificates at the request of pharmaceutical establishments exporting veterinary medicines to third countries (Public Health Code, Article R.5141-127) or medicated feeding stuffs to other European Union Member States or to third countries (Public Health Code, Article R.5141-128).

Application for official release of a batch of inactivated or live rabies vaccines for veterinary use

Updated on 20/06/2022

In accordance with the provisions of Article R. 5141-81 of the Public Health Code, ANSES-ANMV carries out official batch releases of immunological products (OCABR) for rabies vaccines. Batches of inactivated or live rabies vaccines for veterinary use placed on the market in France are subject to an official batch release by the ANMV, which is the competent national authority. This official batch release includes an analysis of the documents relating to the batch manufacture and analytical controls carried out at ANSES's Nancy Laboratory.

Stock shortages of veterinary medicinal products

Updated on 22/06/2022

A stock shortage is defined as a situation in which it is impossible for a beneficiary to obtain supplies of a veterinary medicinal product on the national market.A stock shortage is assessed as critical when it is likely to induce a risk to human health, animal health and welfare.

Quality control of veterinary medicinal products

Updated on 17/06/2022

Each year, within its laboratory, the ANMV's Market Surveillance Unit verifies a series of veterinary medicinal products marketed in France.

Quality defect in a veterinary medicinal product

Updated on 21/06/2022

The veterinary medicinal product manufacturer ensures the quality of each batch before placing it on the market. However, there may be occasions when the manufacturer only becomes aware of an incident that occurred during manufacture or distribution after the medicinal product has been marketed. If the medicinal product does not comply with its marketing authorisation, this is known as a quality defect.

Advertising of veterinary medicinal products

Updated on 21/06/2022

ANSES-ANMV is responsible for controlling the advertising of veterinary medicinal products. For this reason, all advertising documents must be submitted to the Agency, and some even require authorisation, before being distributed. 

COVID-19 cannot be transmitted by either farm animals or domestic animals

Updated on 17/06/2022

The emergence in China in late 2019 of a new coronavirus disease, COVID-19, and its rapid spread around the world have led researchers and health authorities to take prompt and widespread action to better understand the virus involved and how we can protect ourselves from it.It soon emerged that this virus, named SARS-CoV-2, is transmitted from person to person. In France, ANSES was asked to review the available scientific knowledge and assess the possibility of COVID-19 being transmitted via domestic animals or contaminated food. ANSES published its report on 11 March 2020. On the basis of the scientific knowledge available at the time, it concluded that there was no evidence that pets or farmed animals played any role in the spread of the disease. Furthermore, there is nothing to suggest that consumption of contaminated food can lead to infection via the digestive tract.

URGENT : the French agency for veterinary medicinal products works remotely as of March 17th, 2020

Updated on 16/06/2022

Considering the rapidly changing health situation in France, all the staff of the French agency for veterinary medicinal products works remotely as of March 17th, 2020.Therefore, core safety functions shall remain available remotely.You can reach your regular contacts at  the French agency for veterinary medicinal products by e-mail or telephone. See the list of your contacts on the attached link. 

Legal classification of "borderline" products

Updated on 21/06/2022

The French Agency for Veterinary Medicinal Products (ANSES-ANMV) is regularly called upon to qualify the legal status of products with regard to French and EU regulations and to determine whether these products, their placing on the market, their production and distribution fall within the scope of the regulations on veterinary medicinal products.

The article has been added to your library

Go to your library

Pages